Literature DB >> 21646878

HIV-1 treatment as prevention: the good, the bad, and the challenges.

Kumi Smith1, Kimberly A Powers, Angela D M Kashuba, Myron S Cohen.   

Abstract

PURPOSE OF REVIEW: This work focuses on the use of antiretroviral agents to prevent the sexual transmission of HIV-1. RECENT
FINDINGS: Two randomized clinical trials demonstrated that antiretroviral agents provided before exposure to HIV-1 offer substantial protection, ostensibly directly proportional to the concentration of antiretroviral therapy (ART) in the genital secretions. Intense focus on the use of HIV treatment as prevention has led to publication of modeling exercises, ecological studies, and observational studies, most of which support the potential benefits of ART. However, the logistical requirements for successful use of ART for prevention are considerable.
SUMMARY: ART will serve as a cornerstone of combination prevention of HIV-1. Continued research will be essential to measure anticipated benefits and to detect implementation barriers and untoward consequences of such a program, especially increases in primary ART resistance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21646878      PMCID: PMC3666589          DOI: 10.1097/COH.0b013e32834788e7

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  79 in total

1.  Modelling the effect of combination antiretroviral treatments on HIV incidence.

Authors:  M G Law; G Prestage; A Grulich; P Van de Ven; S Kippax
Journal:  AIDS       Date:  2001-07-06       Impact factor: 4.177

2.  Frequency and determinants of unprotected sex among HIV-infected persons: the Swiss HIV cohort study.

Authors:  Barbara Hasse; Bruno Ledergerber; Bernard Hirschel; Pietro Vernazza; Tracy R Glass; Andre Jeannin; John-Marc Evison; Luigia Elzi; Matthias Cavassini; Enos Bernasconi; Dunja Nicca; Rainer Weber
Journal:  Clin Infect Dis       Date:  2010-10-29       Impact factor: 9.079

3.  The unexpected movement of the HIV epidemic in the Southeastern United States: transmission among college students.

Authors:  Lisa B Hightow; Pia D M MacDonald; Christopher D Pilcher; Andrew H Kaplan; Evelyn Foust; Trang Q Nguyen; Peter A Leone
Journal:  J Acquir Immune Defic Syndr       Date:  2005-04-15       Impact factor: 3.731

4.  Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Authors:  Maria J Wawer; Ronald H Gray; Nelson K Sewankambo; David Serwadda; Xianbin Li; Oliver Laeyendecker; Noah Kiwanuka; Godfrey Kigozi; Mohammed Kiddugavu; Thomas Lutalo; Fred Nalugoda; Fred Wabwire-Mangen; Mary P Meehan; Thomas C Quinn
Journal:  J Infect Dis       Date:  2005-03-30       Impact factor: 5.226

5.  Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study.

Authors:  Irálice A V Jansen; Ronald B Geskus; Udi Davidovich; Suzanne Jurriaans; Roel A Coutinho; Maria Prins; Ineke G Stolte
Journal:  AIDS       Date:  2011-02-20       Impact factor: 4.177

Review 6.  Modelling the impact of treatment with individual antiretrovirals.

Authors:  Valentina Cambiano; Andrew N Phillips
Journal:  Curr Opin HIV AIDS       Date:  2011-03       Impact factor: 4.283

7.  Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study.

Authors:  Julio S G Montaner; Viviane D Lima; Rolando Barrios; Benita Yip; Evan Wood; Thomas Kerr; Kate Shannon; P Richard Harrigan; Robert S Hogg; Patricia Daly; Perry Kendall
Journal:  Lancet       Date:  2010-07-16       Impact factor: 79.321

8.  Transmission of drug-resistant HIV-1 is stabilizing in Europe.

Authors:  Jurgen Vercauteren; Annemarie M J Wensing; David A M C van de Vijver; Jan Albert; Claudia Balotta; Osamah Hamouda; Claudia Kücherer; Daniel Struck; Jean-Claude Schmit; Birgitta Asjö; Marie Bruckova; Ricardo J Camacho; Bonaventura Clotet; Suzie Coughlan; Zehava Grossman; Andrzej Horban; Klaus Korn; Leondios Kostrikis; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Elisabeth Puchhammer-Stöckl; Chiara Riva; Lidia Ruiz; Mika Salminen; Rob Schuurman; Anders Sonnerborg; Danica Stanekova; Maja Stanojevic; Anne-Mieke Vandamme; Charles A B Boucher
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

9.  Male genital tract compartmentalization of human immunodeficiency virus type 1 (HIV).

Authors:  Kurt Diem; David C Nickle; Alexis Motoshige; Alan Fox; Susan Ross; James I Mullins; Lawrence Corey; Robert W Coombs; John N Krieger
Journal:  AIDS Res Hum Retroviruses       Date:  2008-04       Impact factor: 2.205

Review 10.  HIV infection of the male genital tract--consequences for sexual transmission and reproduction.

Authors:  A Le Tortorec; N Dejucq-Rainsford
Journal:  Int J Androl       Date:  2009-06-15
View more
  44 in total

1.  Perceived acceptability of home-based couples voluntary HIV counseling and testing in Northern Tanzania.

Authors:  B Njau; M H Watt; J Ostermann; R Manongi; K J Sikkema
Journal:  AIDS Care       Date:  2011-09-22

2.  HIV in Africa: Challenges and Directions for the Next Decade.

Authors:  Bruce L Gilliam; Devang Patel; Rohit Talwani; Zelalem Temesgen
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

3.  Effects of syndemics on HIV viral load and medication adherence in the multicentre AIDS cohort study.

Authors:  M Reuel Friedman; Ron Stall; Anthony J Silvestre; Chongyi Wei; Steve Shoptaw; Amy Herrick; Pamela J Surkan; Linda Teplin; Michael W Plankey
Journal:  AIDS       Date:  2015-06-01       Impact factor: 4.177

Review 4.  Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.

Authors:  Holly Janes; Lawrence Corey; Gita Ramjee; Lindsay N Carpp; Carl Lombard; Myron S Cohen; Peter B Gilbert; Glenda E Gray
Journal:  AIDS Res Hum Retroviruses       Date:  2018-06-19       Impact factor: 2.205

5.  Hypo-osmolar Formulation of Tenofovir (TFV) Enema Promotes Uptake and Metabolism of TFV in Tissues, Leading to Prevention of SHIV/SIV Infection.

Authors:  Peng Xiao; Sanjeev Gumber; Mark A Marzinke; Abhijit A Date; Thuy Hoang; Justin Hanes; Laura M Ensign; Lin Wang; Lisa Rohan; Edward J Fuchs; Craig Hendrix; Francois Villinger
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

6.  High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa.

Authors:  Frank Tanser; Till Bärnighausen; Erofili Grapsa; Jaffer Zaidi; Marie-Louise Newell
Journal:  Science       Date:  2013-02-22       Impact factor: 47.728

Review 7.  Clinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic review.

Authors:  Sonali P Kulkarni; Kavita R Shah; Karthik V Sarma; Anish P Mahajan
Journal:  Am J Public Health       Date:  2013-04-18       Impact factor: 9.308

8.  The indirect impact of antiretroviral therapy: Mortality risk, mental health, and HIV-negative labor supply.

Authors:  Victoria Baranov; Daniel Bennett; Hans-Peter Kohler
Journal:  J Health Econ       Date:  2015-08-24       Impact factor: 3.883

Review 9.  HIV care and treatment experiences among female sex workers living with HIV in sub-Saharan Africa: A systematic review.

Authors:  Kathryn E Lancaster; Dana Cernigliaro; Rose Zulliger; Paul F Fleming
Journal:  Afr J AIDS Res       Date:  2016-12       Impact factor: 1.300

Review 10.  Translation of biomedical prevention strategies for HIV: prospects and pitfalls.

Authors:  Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet
Journal:  J Acquir Immune Defic Syndr       Date:  2013-06-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.